These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37583652)

  • 1. Transformation of Lung Squamous Cell Carcinoma to Small Cell Lung Cancer After Immunotherapy Resistance: A Case Report.
    Wang D; Ye W; Chen D; Shi Q; Ma D
    Cancer Manag Res; 2023; 15():803-808. PubMed ID: 37583652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient with advanced lung squamous cell carcinoma who failed to benefit from albumin bound paclitaxel plus pembrolizumab achieved partial response with second-line treatment of docetaxel plus pembrolizumab: a case report.
    Zhang F; Xu Y; Guo S; Li S; Ma K; Wang J; Wei S
    Ann Palliat Med; 2022 Sep; 11(9):3020-3027. PubMed ID: 36217630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?
    Sehgal K; Varkaris A; Viray H; VanderLaan PA; Rangachari D; Costa DB
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histomorphological transformation from non-small cell lung carcinoma to small cell lung carcinoma after targeted therapy or immunotherapy: A report of two cases.
    Liu H; Chen LH; Zhang ZH; Wang N; Zhuang SH; Chen H; Du J; Pang LJ; Qi Y
    Front Oncol; 2022; 12():1022705. PubMed ID: 36439460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance: A case report.
    Jiang Y; Shou L; Guo Q; Bao Y; Xu X; An S; Lu J
    Medicine (Baltimore); 2021 Aug; 100(32):e26911. PubMed ID: 34397927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation.
    Santoni-Rugiu E; Grauslund M; Melchior LC; Costa JC; Sørensen JB; Urbanska EM
    Lung Cancer; 2017 Nov; 113():14-17. PubMed ID: 29110841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological transformation of lung adenocarcinoma to small cell lung cancer with mutant C797S conferring acquired resistance to osimertinib.
    Ren X; Cai X; Li J; Zhang X; Yu J; Song X; Zhang H; Song X
    J Int Med Res; 2020 Jun; 48(6):300060520927918. PubMed ID: 32600081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Transformation From Non-Small Cell Lung Cancer to Small Cell Lung Cancer During Anti-PD-1 Therapy: A Report of Two Cases.
    Shen Q; Qu J; Sheng L; Gao Q; Zhou J
    Front Oncol; 2021; 11():619371. PubMed ID: 34094904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An EGFR-mutant lung adenocarcinoma that transformed into small-cell lung cancer. A case report.
    Chowaniecova G; Berzinec P; Kosturiakova G; Plank L; Farkasova A; Sekeresova M; Juskanic D; Ondrus D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Dec; 166(4):451-454. PubMed ID: 36036563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study.
    Wang W; Xu C; Chen H; Jia J; Wang L; Feng H; Wang H; Song Z; Yang N; Zhang Y
    Lung Cancer; 2021 May; 155():20-27. PubMed ID: 33714778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected favorable outcome to etoposide and cisplatin in a small cell lung cancer transformed patient: a case report.
    Xie Z; Gu Y; Lin X; Ouyang M; Qin Y; Zhang J; Liu J; Mai S; Zhou C
    Cancer Biol Ther; 2019; 20(9):1172-1175. PubMed ID: 31161851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation of
    Xia G; Huang J; Ni J; Song M; Zhang J; Hofman P; Christopoulos P; Grenda A; Huang M
    Transl Lung Cancer Res; 2023 Mar; 12(3):637-646. PubMed ID: 37057117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation.
    Abdallah N; Nagasaka M; Abdulfatah E; Shi D; Wozniak AJ; Sukari A
    Lung Cancer (Auckl); 2018; 9():85-90. PubMed ID: 30498383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of non-small cell lung cancer transforming to small cell lung cancer and its response to EGFR-TKI: a case report.
    Fang G; Liu W; Shang Y; Huo R; Shi X; Wang Y; Li J
    Ann Transl Med; 2022 Jan; 10(2):115. PubMed ID: 35282065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced Lung Adenocarcinoma with EGFR 19-del Mutation Transformed into SCC after EGFR-tyrosine Kinase inhibitors Treatment: A Case report.
    Ji XZ; Liu ZD; Ye YP; Li Q; Liu XJ; Zhou MH; Jin Y
    World J Clin Cases; 2024 Jul; 12(20):4405-4411. PubMed ID: 39015891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Re-Sensitization to Gefitinib in Lung Adenocarcinoma Harboring EGFR Mutation and High PD-L1 Expression After Immunotherapy Resistance, Which Finally Transform Into Small Cell Carcinoma.
    Zhai X; Liu J; Liang Z; Li Z; Liu Y; Huang L; Wang W; Luo F
    Front Oncol; 2021; 11():661034. PubMed ID: 34249697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durable response to durvalumab-based immunochemotherapy in small-cell lung carcinoma transformation from EGFR-mutant non-small cell lung cancer: A case report.
    Li YC
    Thorac Cancer; 2022 Mar; 13(5):775-779. PubMed ID: 35088537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic changes of acquired T790M mutation and small cell lung cancer transformation in a patient with EGFR-mutant adenocarcinoma after first- and third-generation EGFR-TKIs: a case report.
    Ma S; He Z; Fu H; Wang L; Wu X; Zhang Z; Wang Q
    Transl Lung Cancer Res; 2020 Feb; 9(1):139-143. PubMed ID: 32206560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of genetic sequencing in patients with lung adenocarcinoma with transformation to small cell lung cancer: a case report and systematic review.
    Zhang C; Lin L; Guo X; Chen P
    Transl Cancer Res; 2020 May; 9(5):3725-3733. PubMed ID: 35117735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small cell lung cancer transformation and tumor heterogeneity after sequential targeted therapy and immunotherapy in EGFR-mutant non-small cell lung cancer: A case report.
    Yang MH; Yu J; Cai CL; Li W
    Front Oncol; 2022; 12():1029282. PubMed ID: 36568150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.